Explainer

Peptide Experience Survey: Help Us Understand What the Community Cares About

Help us understand what the peptide community cares about — without sharing anything sensitive. This survey is designed to collect only non-sensitive, non-identifiable information about your research interests and the information landscape you've encountered. It does not ask for dosing, medical history, identifiable health data, or intended use. Your responses help us identify trends, prioritize editorial coverage, and fill the information gaps that matter most to readers.

Collected

What the Survey Collects

The survey asks about your experience as a reader and researcher of peptide information. The questions are framed around what topics you encounter, what information you find lacking, and what safety questions matter to you — not about your personal use, health, or behavior. This keeps the survey within the site's editorial boundary while still providing useful signal about community interests.

Key points

• Peptide categories of interest: which compound families or topics you read about (e.g., GLP-1 agonists, growth hormone secretagogues, recovery peptides, cosmetic peptides).
• Reason for interest: why you research peptides (e.g., scientific curiosity, professional research, general awareness, evaluating claims you encountered online).
• Information gaps noticed: where you found the existing literature, regulatory records, or community content lacking or contradictory.
• Safety concerns: what safety, quality, or regulatory questions you have that aren't well addressed by current sources.

Excluded

What the Survey Does NOT Collect

The survey is deliberately scoped to exclude any information that could constitute health data, treatment guidance, or identifiable personal information. This boundary aligns with the site's editorial policy, the research survey plan, and the community guidelines. If a question feels like it might reveal personal health information, it is not in this survey. The survey cannot and will not ask you to share anything that would turn an information index into a treatment record.

Key points

• No dosing information: the survey does not ask about doses, frequency, titration, cycling, or route of administration — yours or anyone else's.
• No medical history: the survey does not ask about conditions, diagnoses, medications, or any health status.
• No identifiable health data: the survey does not collect names, email addresses tied to health information, or any data that could link your responses to your identity or medical records.
• No intended use: the survey does not ask what you plan to do with the information, whether you intend to use peptides yourself, or what your personal goals are.

Privacy

Privacy Protections

Your responses are anonymous. The survey does not collect personally identifiable information, does not use tracking cookies beyond what is necessary to prevent duplicate submissions, and does not link responses to your browsing history, account, or IP address in any published output. Results are published only in aggregate form — no individual response is ever surfaced, quoted, or attributed. If you are uncomfortable answering any question, skip it. The survey is voluntary and you can stop at any time.

Key points

• Anonymous by design: no name, email, account, or identifier is required or requested.
• No PII collected: the survey form does not ask for personally identifiable information at any stage.
• Aggregate-only publication: results are published as summary statistics and trend descriptions, never as individual responses.
• No ad pixels or third-party analytics on the survey form: the survey page excludes analytics and advertising trackers that could fingerprint respondents.

Usage

How Survey Data Is Used

Survey responses inform the site's editorial priorities. When many readers report the same information gap or safety concern, that signals a topic worth covering in a dedicated explainer, guide, or source review. Aggregate results may be published as trend reports so the community can see what topics are drawing attention and where the information landscape is thin. The data also helps identify which peptide categories are most actively researched, which in turn shapes which compound pages and comparisons get prioritized for updates.

Key points

• Published as aggregate reports: summary statistics and trend descriptions, never individual responses.
• Identifies trends: recurring information gaps and safety concerns signal where editorial coverage is needed.
• Informs editorial coverage: topics with high reader interest and poor source coverage get prioritized for new explainers and guides.
• Does not inform product recommendations, vendor rankings, or purchasing guidance — the survey supports editorial planning only.

Reference

Survey Plan and Related Policies

The survey follows the research survey plan documented in the repository. That plan distinguishes between active V1 fields — which are non-sensitive and support segmentation and editorial planning — and future survey tracks that would require additional consent infrastructure before launch. The community guidelines and editorial policy define the boundaries within which the survey operates. Readers are encouraged to review these documents before participating.

Key points

• The research survey plan (docs/research-survey-plan.md in the repository) defines V1 active fields and outlines future survey tracks that require additional consent layers before they can launch.
• The editorial policy (docs/editorial-policy.md) defines what this site will and will not publish — the survey inherits the same boundaries.
• The community guidelines (/access-paths/community-guidelines/) define what is and is not allowed in reader-contributed content, including survey responses.
• The sensitive health-context survey track described in the research survey plan is NOT active. It will not launch until explicit consent copy, retention policy, deletion paths, and breach-response processes are in place.

Related pages